15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering Dentsply Sirona Inc, 3 rate it Buy or better, 9 sit at Hold, and 2 rate it Sell or worse, a hold consensus. Targets span $10.00 to $17.00, a moderate spread. The average target of $13.83 sits 22% above the current $11.38. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.46 next quarter toward $1.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Hold
Strong Buy00%
Buy321%
Hold964%
Sell214%
Strong Sell00%
Based on 14 analysts giving stock ratings to Dentsply Sirona Inc.
As of Sep, 3 of 13 firms rate XRAY a Buy (8 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
XRAY EPS & revenue forecast
EPS · NEXT QUARTER
$0.46
Range $0.34 – $0.54 · 16 analysts · +70% YoY
Next period, 16 analysts expect Dentsply Sirona Inc to earn $0.46 a share (range $0.34 – $0.54), versus $0.27 a year earlier. Full-year consensus is $1.50, growing to $1.52 the year after.
REVENUE · NEXT QUARTER
$936.3M
Range $895.4M – $960.0M · 16 analysts · -3% YoY
Revenue is expected to reach $936.3M (range $895.4M – $960.0M), -2.6% year-over-year. Full-year consensus is $3.6B, rising to $3.6B next year.
Top analysts covering Dentsply Sirona Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XRAY.
#1
Erin Wright
Morgan Stanley · Rank #36
Hold
No targeton XRAY
Overall win rate
59%
+ Follow
#2
Jonathan Block
Stifel · Rank #205
Hold
$14.00+23.1% to target
Overall win rate
41%
+ Follow
#3
Jason Bednar
Piper Sandler · Rank #276
Hold
$14.00+23.1% to target
Overall win rate
35%
+ Follow
#4
David Saxon
Needham · Rank #347
Hold
No targeton XRAY
Overall win rate
32%
+ Follow
#5
Michael Petusky
Barrington Research · Rank #373
Buy
$17.00+49.5% to target
Overall win rate
31%
+ Follow
XRAY stock forecast FAQ
What is XRAY's average 12-month price target?+
The 11 analysts with a live target average $13.83 for Dentsply Sirona Inc over the next 12 months, ranging from a $17.00 high to a $10.00 low.
Is XRAY stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 14 analyst ratings, 3 are Buy or Strong Buy, 9 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for XRAY?+
The Street-high target is $17.00 (UBS), and the Street-low is $10.00 (Citigroup). The average of all 11 active targets is $13.83.
How many Wall Street analysts cover XRAY?+
14 analysts have an active rating on Dentsply Sirona Inc, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering XRAY?+
Among analysts who currently cover XRAY, Erin Wright of Morgan Stanley has the strongest overall Quantellect track record (Rank #36). Their current call is Hold.
What is Dentsply Sirona Inc's projected EPS for next quarter?+
The consensus estimate is $0.46 per share (range $0.34 – $0.54) across 16 analysts. Full-year EPS is projected at $1.50, rising to $1.52 the following year.
How much revenue is Dentsply Sirona Inc expected to report next quarter?+
Consensus revenue is $936.3M (range $895.4M – $960.0M). Full-year revenue is projected at $3.6B, growing to $3.6B next year.
Have analysts been upgrading or downgrading XRAY lately?+
As of Sep, 3 of 13 firms rate XRAY a Buy (8 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XRAY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
